The boards of CME and NEX are pleased to announce that they have received clearance under the Hart-Scott-Rodino Act from the United States Department of Justice - Antitrust Division for the proposed acquisition of NEX by CME and Bidco.
CME and NEX have also received the relevant regulatory approvals from the FCA and regulators in the United States, Germany, Italy and Sweden, and have made the requisite pre-notifications in Hong Kong.
Completion of the Acquisition remains subject to the satisfaction or waiver of the remaining Conditions, including competition clearance being received from the UK Competition and Markets Authority and the sanctioning of the Scheme by the Court. CME and NEX still expect the Scheme to become effective by year end 2018.
Terms used but not defined in this announcement have the meaning given to them in the Rule 2.7 announcement released by NEX and CME on 29 March 2018.
